These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7846083)

  • 1. Formulation and in vitro study of antibacterial vaginal suppositories.
    Regdon G; Gombkötö S; Regdon G; Selmeczi B
    Pharm Acta Helv; 1994 Dec; 69(3):141-8. PubMed ID: 7846083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Formulation and in vitro investigation of antibacterial vaginal suppositories. Part 1. Considerations in selecting the vehicle. Methods and results of the physical examination].
    Tariné Gombkötö Z; Regdon G; Regdon G; Selmeczi B
    Acta Pharm Hung; 1992 Nov; 62(6):295-301. PubMed ID: 1488915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Formulation and in vitro investigation of antibacterial vaginal suppositories. Part 2. In vitro membrane diffusion and microbiologic studies].
    Tariné Gombkŏtö Z; Molnár J; Farkasné Gunics G; Regdon G; Selmeczi B
    Acta Pharm Hung; 1992 Nov; 62(6):302-9. PubMed ID: 1488916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of suppository bases on the release properties of a potent antimicrobial agent (C31G).
    Caliş S; Sumnu M; Hincal AA
    Pharmazie; 1994 May; 49(5):336-9. PubMed ID: 8016179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of rectal amoxicillin (RAMOX) for the treatment of pneumonia in children.
    Hanning SM; Matiz S; Krasser K; Orlu M; Dodoo C; Gaisford S; Tuleu C
    Drug Deliv Transl Res; 2021 Jun; 11(3):944-955. PubMed ID: 32588280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acetaminophen-containing suppositories in vitro and in vivo].
    Regdon G; Szikszay M; Gebri G; Regdon G
    Acta Pharm Hung; 1994 Mar; 64(2):45-9. PubMed ID: 8017207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of intravaginal vardenafil suppositories targeting a complementary treatment to boost in vitro fertilization process.
    Gomaa E; Abu Lila AS; Hasan AA; Ghazy FS
    Eur J Pharm Sci; 2018 Jan; 111():113-120. PubMed ID: 28964952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in Vitro Release of Indomethacin from Suppositories: Effects of Bases and Comparison of Different Dissolution Methods.
    Mori K; Hori S; Kawata T; Kogure S; Matsumoto K; Hasegawa T; Akimoto M
    Chem Pharm Bull (Tokyo); 2017; 65(7):674-677. PubMed ID: 28674341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro release of amoxycillin from lipophilic suppositories.
    Webster JA; Dowse R; Walker RB
    Drug Dev Ind Pharm; 1998 Apr; 24(4):395-9. PubMed ID: 9876601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preformulation experiences and in vitro model studies with spironolactone-containing suppositories.
    Regdon G; Deák D; Regdon G; Muskó Z; Erös I
    Pharmazie; 2001 Jan; 56(1):70-3. PubMed ID: 11213791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of pyrazolone derivatives from suppositories formulated with hydrophilic and hydrophobic bases.
    Bećirević M; Petricić V
    Pharmazie; 1986 May; 41(5):338-40. PubMed ID: 3737665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Microbiological validation of the composition of "decaceol", an antiseptic prolonged-release drug].
    Dykyĭ IL; Zaĭtsev OI; Filimonova NI
    Lik Sprava; 2002; (7):114-7. PubMed ID: 12587327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of betadine vaginal suppository treatment in pregnancy].
    Gimes G; Péter F
    Acta Pharm Hung; 1997 Nov; 67(6):249-53. PubMed ID: 9480620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sildenafil vaginal suppositories: preparation, characterization, in vitro and in vivo evaluation.
    Shanmugam S; Kim YH; Park JH; Im HT; Sohn YT; Kim KS; Kim YI; Yong CS; Kim JO; Choi HG; Woo JS
    Drug Dev Ind Pharm; 2014 Jun; 40(6):803-12. PubMed ID: 23781859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NITROFURAZONE-ESTROGEN VAGINAL SUPPOSITORIES IN THE TREATMENT OF ATROPHIC VAGINITIS.
    FRIEDMAN JA; OLSEN N
    J Am Geriatr Soc; 1965 Sep; 13():828-31. PubMed ID: 14341031
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of in vitro model examinaitons with respect to drug release from suppositories].
    Regdon G; Vágó I; Mándi E; Regdon G; Erós I
    Acta Pharm Hung; 2000 Apr; 70(2):45-51. PubMed ID: 11192740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Production technology and in vitro study of rectal suppositories containing chloroquine phosphate].
    Regdon Géza JR; Schirm I; Pittmann A; Regdon G
    Acta Pharm Hung; 1995 Mar; 65(2):45-50. PubMed ID: 7793289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The formulation of an effective topical antibacterial product containing Ocimum gratissimum leaf essential oil.
    Orafidiya LO; Oyedele AO; Shittu AO; Elujoba AA
    Int J Pharm; 2001 Aug; 224(1-2):177-83. PubMed ID: 11472827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A NEW SUPPOSITORY FOR TREATMENT OF MIXED TRICHOMONAL VAGINAL INFECTIONS.
    GIORLANDO SW; MUSCILLO CG; CASH N
    Obstet Gynecol; 1964 Sep; 24():477-80. PubMed ID: 14207353
    [No Abstract]   [Full Text] [Related]  

  • 20. The release of isoconazole nitrate from different suppository bases: in-vivo release of drug labelled with 99mTc in rabbits.
    Asikoglu M; Ertan G; Ercan MT; Duman Y
    J Pharm Pharmacol; 1995 Sep; 47(9):717-20. PubMed ID: 8583381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.